Our immunohistochemical study also revealed that PD-L1 protein expression on ATLL cells was associated with poor prognosis, while the ATLL cases in which tumor-microenvironment cells express PD-L1 showed favorable prognosis in the aggressive type (Figure 2B) [63,71,72]. This evidence concerns the gene CD274 and neoplasm.